The results of oVRcome’s newly published virtual reality study were recently featured in several media articles, including ASCO Post, Vanderbilt Health News, and HemOnc Today. In the study, patients who used VR during chemotherapy infusion visits reported lower pain and stress, lower median heart rates, and high satisfaction compared with patients doing usual activities such as reading or watching TV.
These findings support oVRcome’s mission to make immersive technology a practical, accessible tool for improving comfort during medical care.
